KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gilead Sciences (GILD) Income from Non-Controlling Interests (2016 - 2023)

Gilead Sciences (GILD) has disclosed Income from Non-Controlling Interests for 14 consecutive years, with -$6.0 million as the latest value for Q2 2023.

  • For the quarter ending Q2 2023, Income from Non-Controlling Interests changed N/A year-over-year to -$6.0 million, compared with a TTM value of -$32.0 million through Jun 2024, up 23.81%, and an annual FY2023 reading of -$52.0 million, down 100.0% over the prior year.
  • Income from Non-Controlling Interests was -$6.0 million for Q2 2023 at Gilead Sciences, up from -$26.0 million in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at -$3.0 million in Q3 2019 and bottomed at -$26.0 million in Q1 2023.
  • Average Income from Non-Controlling Interests over 5 years is -$7.7 million, with a median of -$7.0 million recorded in 2019.
  • The sharpest move saw Income from Non-Controlling Interests crashed 800.0% in 2019, then changed 0.0% in 2020.
  • Year by year, Income from Non-Controlling Interests stood at -$7.0 million in 2019, then changed by 0.0% to -$7.0 million in 2020, then changed by 0.0% to -$7.0 million in 2021, then soared by 57.14% to -$3.0 million in 2022, then plummeted by 100.0% to -$6.0 million in 2023.
  • Business Quant data shows Income from Non-Controlling Interests for GILD at -$6.0 million in Q2 2023, -$26.0 million in Q1 2023, and -$3.0 million in Q3 2022.